NCT02081287View on ClinicalTrials.gov

Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 30, 2018

Study Completion Date

July 30, 2018

Conditions
Bipolar DisorderManic Depression
Interventions
DRUG

IP6

IP6 2,000 -3,000 mg per day given orally in two doses

DRUG

Lamotrigine

Dose up to 200 mg per day over 10 weeks

Trial Locations (1)

92161

VA San Diego Healthcare System, San Diego

All Listed Sponsors
collaborator

The Depressive and Bipolar Disorder Alternative Treatment Foundation

OTHER

lead

San Diego Veterans Healthcare System

FED

NCT02081287 - Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder? | Biotech Hunter | Biotech Hunter